When tirzepatide isn't working: troubleshooting non-response

The trial data on tirzepatide includes a meaningful tail of patients who respond poorly. SURMOUNT-1 reported that about 15-20% of patients on tirzepatide didn't reach the 5% weight-loss threshold by week 72. This is a smaller non-response fraction than older anti-obesity drugs but it's not zero, and the question that drives a lot of reader email is: am I in that group, or is something else going on?

The answer is usually that something else is going on. True biological non-response is rare; workflow failures that look like non-response are common. Here's the decision tree.

Define non-response first

Before triaging, what does "not working" actually mean?

Week-by-week scale variance: Normal. Weight fluctuates 1-3kg per day from food, water, and sleep. Daily weighing makes everyone look like a non-responder some weeks.

Plateau after early loss: Probably normal. Most people see most of their loss in months 2-6 and then plateau. A plateau at month 4 is the body adapting, not the drug failing.

No measurable loss at week 8 on 2.5mg: Possibly normal. The 2.5mg dose is a starter, not a treatment dose. Most loss happens after the step-up to 5mg+.

No measurable loss at week 8-12 on 5mg+: Worth investigating. By 12 weeks at maintenance dose, most patients have lost 4-7% body weight.

Loss less than 5% at month 6 on full dose: This is the meaningful non-response definition. Worth a real workup.

The five things that look like non-response but aren't

Inadequate dose. Some patients stay at 2.5mg or 5mg for months while their prescriber assumes they're progressing. The dose ramp is supposed to escalate. If you've been at the same dose for 12+ weeks and aren't seeing progress, the answer is often "step up to 7.5mg or 10mg," not "the drug isn't working."

Calorie creep. The drug suppresses appetite but doesn't enforce caloric deficit if you eat past the suppression. A patient who's drinking 800 calories per day in lattes and protein shakes is in maintenance not deficit, and the drug can't compensate. Track intake honestly for two weeks to rule this out.

Missed doses. Inconsistent dosing produces inconsistent results. If you've missed multiple doses (forgot, traveled, supply gap), the cumulative effect is muted. See missed dose for the catch-up math.

Counterfeit or under-dosed product. Particularly for compounded sources or research-chem-leaning operators, product quality varies. If you've never had a side effect (no nausea even briefly, no appetite reduction, no constipation), you may not be getting actual tirzepatide.

Other medications working against you. Some psychiatric medications (specifically certain antidepressants) and some corticosteroids cause weight gain that can offset GLP-1 weight loss. Your scale is the net effect of both.

The biological non-response patterns

If the workflow patterns above don't apply, biological non-response is the residual category. Within it:

Genetic variants in GLP-1 receptor signaling. Real but uncommon. Some patients have polymorphisms in the GLP-1 receptor gene that reduce drug efficacy. Not currently routinely testable.

Severe insulin resistance. Patients with very high baseline insulin resistance sometimes respond more slowly to GLP-1s. The drug works but the metabolic improvement is incremental.

PCOS and androgen-related obesity. Some patients with PCOS have a different response profile. Tirzepatide still works but often less dramatically; the response curve is flatter.

Cushing's syndrome or other endocrine disorders. Rare but worth ruling out if the response is meaningfully worse than expected. A patient with undiagnosed Cushing's will have weight that's resistant to most interventions.

Severe sleep apnea or persistent metabolic dysfunction. Independent factors that suppress weight loss; addressing them often unlocks the GLP-1 response.

The diagnostic decision tree

If you're not seeing meaningful progress at month 3-4 on full dose:

Step 1: Audit dose. Are you actually at maintenance dose (5mg+)? If not, step up.

Step 2: Audit intake. Track every calorie for 14 days. Be honest. Most "non-response" cases resolve here.

Step 3: Audit dose consistency. Have you missed any doses in the last 6 weeks? Have your supply runs been clean? Replace if not.

Step 4: Audit product source. If you've never had any side effect, even briefly, consider whether your product is real. Switch to a verified source for one cycle and compare.

Step 5: Audit other medications. Has anything in your medication list changed? Steroids, certain antidepressants, hormonal medications can all suppress GLP-1 response.

Step 6: Audit sleep and stress. Severe sleep deprivation and chronic high cortisol both suppress weight loss. The drug is working harder than it appears against an opposing biological signal.

If steps 1-6 are clean and you're still not progressing at month 6, you're probably in the genuine biological non-response category. This is the moment for a real workup.

What a real workup looks like

A prescriber familiar with non-responders will typically order:

• A basic metabolic panel + lipid panel + HbA1c (rule out anything obvious)
• TSH (thyroid function affects metabolism)
• Cortisol screening (overnight test) if there's any suspicion of Cushing's
• Insulin and HOMA-IR (quantify insulin resistance)
• Sex hormones if PCOS or hypogonadism is on the table

Based on the workup:

If something is identified: Treat the underlying issue first. The GLP-1 response often improves once the secondary issue is addressed.

If nothing is identified and you're a true non-responder: Options include switching to a different GLP-1 (the response patterns are partially independent · some patients respond to semaglutide but not tirzepatide, or the reverse), trying retatrutide if available in your region, considering bariatric surgery if appropriate, or accepting that the response is what it is and adjusting expectations.

What I'd actually recommend

If you've been on tirzepatide for 12 weeks at a maintenance dose and the scale has barely moved:

First, audit intake honestly. Do this before requesting a workup; about 60% of "non-response" cases I see in reader email resolve at this step.

Second, confirm you're at the right dose for your situation. Most patients need to be at 7.5mg or higher to see meaningful response.

Third, ask your prescriber for the basic non-response workup (TSH, cortisol screen, HbA1c, insulin). It's cheap and rules out the secondary causes.

Fourth, if all of that is clean, you're in the genuine non-response group. Talk to your prescriber about switching molecules or considering alternative paths. About one-third of tirzepatide non-responders respond to semaglutide; the molecules aren't perfectly correlated.

Don't push tirzepatide higher than 15mg looking for response. Patients who max out the dose without response are usually the patients who needed a different intervention, not more drug.